Zhaoyang Zhong
Chongqing, 408000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Rbp-Jκ controls NK cell late maturation and migration via chromatin landscape remodeling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 01, 2026
Identification of a JAK-STAT-miR155HG positive feedback loop in regulating natural killer (NK) cells proliferation and effector functions.
Journal: Acta pharmaceutica Sinica. B
Published: October 15, 2024
METTL3 positively regulates the development and cytotoxicity of human embryonic stem cells-derived NK cells.
Journal: Cellular immunology
Published: September 05, 2024
Inhibitors of APE1 redox and ATM synergistically sensitize osteosarcoma cells to ionizing radiation by inducing ferroptosis.
Journal: International immunopharmacology
Published: April 19, 2024
The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions.
Journal: Cancer immunology research
Published: April 28, 2023
mTOR Signaling Promotes Rapid m6A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions.
Journal: Cancer immunology research
Published: April 19, 2023
Docosahexaenoic acid supplementation represses the early immune response against murine cytomegalovirus but enhances NK cell effector function.
Journal: BMC immunology
Published: November 07, 2021
Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
Journal: Frontiers in molecular biosciences
Published: September 29, 2020
Landscape of active enhancers developed de novo in cirrhosis and conserved in hepatocellular carcinoma.
Journal: American journal of cancer research
Published: August 05, 2020
ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the Wnt/β-catenin signaling pathway in vitro.
Journal: Annals of translational medicine
Published: May 02, 2020
Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma.
Journal: Oncology reports
Published: October 14, 2019
Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment.
Journal: Cell biochemistry and function
Published: May 16, 2019
Last Updated: 09/26/2026